GALNS rs398123439: Understanding Carrier Status
The rs398123439 variant is a specific genetic change located within the GALNS gene. It is recognized in clinical databases as a carrier mutation associated with Mucopolysaccharidosis type IV-A, an inherited metabolic condition.
What each genotype means
Typical GALNS genotype
This genotype represents the common sequence at this position in the GALNS gene. It is not associated with the carrier status for Mucopolysaccharidosis type IV-A described for this variant.
This is the most common genotype observed in the general population.
Carrier of MPS IV-A mutation
This genotype indicates you carry one copy of the variant associated with Mucopolysaccharidosis type IV-A, an autosomal recessive condition. Being a carrier typically does not cause symptoms, but you should consult with a genetic counselor or physician to understand the implications for family planning.
The frequency of this specific heterozygous genotype is rare in the general population.
Potential MPS IV-A risk
This genotype indicates the presence of two copies of the variant. Because Mucopolysaccharidosis type IV-A is an autosomal recessive condition, individuals with two copies of a pathogenic variant may be at risk for the condition, which affects skeletal and connective tissue development. Please discuss these results with a medical geneticist or your primary healthcare provider for clinical context.
This homozygous genotype is extremely rare in the general population.
What is the rs398123439 Variant?
The rs398123439 variant is a single nucleotide polymorphism (SNP) found on chromosome 16. In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is located within the GALNS gene, which provides instructions for making an enzyme called N-acetylgalactosamine-6-sulfatase. Genetic variants like rs398123439 are identified through advanced sequencing technologies that allow researchers to pinpoint precise locations in the genome that may contribute to specific health traits or conditions. Because this variant is categorized as a carrier mutation, it is primarily studied for its potential to influence the inheritance of recessive disorders. Understanding the exact location and nature of such variants is a fundamental step in modern genomic research, helping scientists map the relationship between DNA sequences and biological function.
The Role of the GALNS Gene
The GALNS gene is essential for the proper function of lysosomes, which are the recycling centers of the cell. It encodes the enzyme N-acetylgalactosamine-6-sulfatase, which is responsible for breaking down complex sugar molecules known as glycosaminoglycans (GAGs). When the GALNS gene contains pathogenic variants that significantly reduce or eliminate enzyme activity, GAGs can accumulate within cells, leading to a condition known as Mucopolysaccharidosis type IV-A, or Morquio syndrome type A. This is an autosomal recessive disorder, meaning that an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the clinical symptoms of the condition. The gene is located on the long arm of chromosome 16 and has been the subject of extensive study, with hundreds of different variants identified worldwide that can impact its enzymatic efficiency.
Research and Clinical Evidence
Research into rs398123439 identifies it as a carrier mutation for Mucopolysaccharidosis type IV-A. In clinical genetics, a carrier is an individual who possesses one copy of a recessive variant but does not typically exhibit the symptoms of the associated disorder. The evidence strength for this variant is currently classified as moderate, reflecting its documented presence in individuals and its association with the GALNS gene. Scientific literature, including data found in repositories like ClinVar and various peer-reviewed studies, highlights that the functional impact of GALNS variants can vary widely, ranging from mild to severe clinical presentations. Because the field of genomics is rapidly evolving, ongoing research continues to refine our understanding of how specific variants like rs398123439 interact with other genetic factors to influence health outcomes. It is important to note that the presence of a carrier variant does not equate to a diagnosis of the disease itself.
Population Frequency
Specific population frequency data for the rs398123439 variant is not widely recorded in major public databases. Genetic variants associated with rare conditions like Mucopolysaccharidosis type IV-A are often found at very low frequencies in the general population, sometimes appearing as founder mutations within specific ethnic or geographic groups. Because large-scale genomic studies often focus on common variants, rare variants like this one may lack comprehensive frequency statistics across diverse ancestries. The absence of recorded frequency data does not imply that the variant is absent in certain populations, but rather that it has not been frequently captured in the cohorts currently represented in public genomic datasets. Researchers continue to expand the diversity of these datasets to better understand the global distribution of rare genetic variants.
Interpreting Your Genetic Information
If you have received information regarding your status for the rs398123439 variant, it is important to understand what this means in a clinical context. Being a carrier for an autosomal recessive condition is common, as most people carry several such variants in their genome. This information is primarily used for reproductive planning and family health history assessment. It is not a medical diagnosis, and it does not mean you have or will develop Mucopolysaccharidosis type IV-A. If you are concerned about your carrier status or the implications for your family, the most appropriate step is to consult with a certified genetic counselor or a medical geneticist. These professionals can provide context based on your personal and family history, explain the inheritance patterns, and discuss any relevant testing options for partners or family members. Always rely on qualified healthcare providers to interpret genetic findings rather than attempting to diagnose yourself.
How common is this variant?
There is no specific population frequency data recorded for this variant in major public genomic databases.
Frequently asked questions
What does it mean to be a carrier for a genetic condition?
Being a carrier means you have one copy of a gene variant that is associated with a recessive condition, but you do not have the condition yourself. You typically need to inherit two copies of the variant—one from each parent—to be affected by the disorder.
Is rs398123439 a diagnosis for Morquio syndrome?
No, identifying this variant does not constitute a diagnosis of Mucopolysaccharidosis type IV-A (Morquio syndrome). It simply identifies you as a carrier of a specific genetic change in the GALNS gene.
Should I be worried if I have this variant?
Most people are carriers for several recessive genetic variants. If you are concerned about your results, you should speak with a genetic counselor who can explain the implications based on your specific family history and reproductive goals.
Where can I find more information about the GALNS gene?
You can find reliable information about the GALNS gene and related conditions on government-sponsored websites like MedlinePlus Genetics and the National Center for Biotechnology Information (NCBI) Gene database.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs398123439?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GALNS
This variant is associated with carrier status for Mucopolysaccharidosis type IV-A.
This variant is associated with carrier status for Mucopolysaccharidosis type IV-A (Morquio syndrome type A).
This variant serves as a carrier marker for Mucopolysaccharidosis type IV-A, a lysosomal storage disorder.
This variant is identified as a carrier mutation for Mucopolysaccharidosis type IV-A (Morquio syndrome).
This variant is a pathogenic mutation linked to carrier status for Mucopolysaccharidosis type IV-A.
This variant is identified as a carrier mutation for Mucopolysaccharidosis type IV-A.
